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. They have very complex pathological types, including germ cell tumors, pineal parenchymal tumors, gliomas, meningiomas, ependymomas, lymphomas, neuronal tumors, and metastases 2, 3 . Treatment strategies for these tumors vary, and many experts suggest that PRT mana gement strategies depend on an accurate histologic diagnosis. Radiotherapy and chemotherapy are usually suggested for radiosensitive or malignant tumors, while surgical resections are recommended for benign tumors [4] [5] [6] [7] [8] [9] . However, it is not possible to obtain accurate pathologi cal diagnoses in a subset of PRT patients, either because open biopsy (craniotomy) is high risk or because stereotactic bio p sy carries a certain rate of diagnostic failure. Although sufficient specimen and total or partial tumor resection are options in open biopsy, the surgery is high risk and has a 5-20% morbi dity (major or minor) rate [4] [5] [6] , even with advancements in microsurgical techniques. In addition, the operation requires extensive technical skills and experience 10 . Stereotactic bio psy is less likely to result in mortality and morbidity, but yields only a small pathology specimen, which can be challenging for even experienced neuropathologists 11 . Moreover, for some tumors with a combination of benign and malignant components, it is hard to make an accurate pathological diagnosis with a limited amount of biopsy material 2, 3 . There is also a risk of hemorrhage because of the nature of tumor vasculature and the density of vascular structures in the pineal region 12 . Recently, neuroendoscopy has been used in the initial management of PRTs, as this minimally invasive technique can obtain more tumor tissue during biopsy. However, 6-25% of patients had a negative pathological diagnosis [7] [8] [9] , and some experts still argue that this procedure provides limited tissue samples 13 .
In patients with a negative pathological diagnosis, radio therapy could be a viable alternative treatment because some PRTs are radiosensitive 14 . This is especially true in Asia 15, 16 , where radiosensitive PRTs account for a higher percentage 17, 18 . Kanamori and colleagues 16 showed that 32 of 41 PRT patients treated with neoadjuvant chemotherapy and radiation therapy without histological verification achieved an excellent response.
Gamma knife surgery (GKS) is a stereotactic radiation treatment with better safety and fewer associated complications; it avoids adjacent brain tissues but delivers a high dose of radiation to the target lesion. Here, we report our expe rience using GKS for pathologynegative PRT patients.
metHoD
We retrospectively reviewed data from 17 PRTs patients treated with GKS who had no or unclear pathological diagnoses in our department from January 2005 to December 2009 ( Table 1 ). The mean age of the patients was 25.5 years (1265 years), and the male:female ratio was 15:2. All patients had preoperative threedimensional cranial magnetic resonance imaging (MRI) and underwent laboratory tests for the tumor markers alpha fetoprotein (AFP) and beta chorionic gonadotrophin (βHCG). The average tumor diameter was 2.20 cm (range, 1.1-3.6 cm), and 88.2% of tumors were <3 cm.
A Leksell stereotactic frame (Elekta Instruments AB, Stockholm, Sweden) was used for all patients, and images for dose planning were obtained with a 1.5Tesla superconducting magnetic resonance scanner (Siemens, Erlanger, Germany). Dose planning was carried out with Leksell Gamma Plan (Elekta Instruments AB). The average marginal dose was 13.7 Gy (range, 12-15 Gy), and the average isodose line was 48.5% (range, 45-50%). Ventriculoperitoneal shunt (VPS) was employed in patients with high intracranial pressure before GKS.
Clinical followup was by means of patient interview ( face to face or telephone) and regular MRI examination eve ry 36 months. The effects of GKS were evaluated based on clinical manifestations and radiological changes. MRI ima ges were analyzed by two independent experienced radio logists according to a fivegrade system, including complete response (CR), partial response (PR), minor response (MR), no change (NC), and progression (PG). Total response rate was defined as the percentages of CR and PR, and control rate was the ratio of CR, PR, MR, and NC to total 19 . Karnofsky performance status (KPS) was assessed at admission and 6 months after GKS, and these two scores were compared to investigate the influence of GKS on quality of life.
resuLts
Sixteen of 17 cases (94.1%) were followed up over a mean of 33.3 months (range, 264 months), and one was lost to followup. Thirteen patients (81.3%) were alive at the final followup (Table 1) . CR was achieved in nine cases (56.3%), PR in three cases (18.8%), NC in one case (6.3%), and PG in three cases (18.8%); no patients showed MR. The total response rate was 75%, and the control rate was 81.3% (Table 2) . VPS was performed in 13 cases (76.5%), as high intracranial pressure is the main symptom in patients with PRTs. No extra nervous system metastases were found.
Serum testing for tumor markers (AFP and β-HCG) was negative in nine (52.9%) cases, and either one or both were positive in eight cases (47.1%). The relationship bet ween tumor markers and response revealed that patients with negative tumor markers had a tendency to achieve a CR regar dless of whether they were treated with GKS plus WBSRT and chemotherapy or GKS only (Table 3) .
Nine patients had further wholebrain and spinal cord radiotherapy (WBSRT) and chemotherapy (Chemo) 69 months after GKS. The whole brain and spinal cord were fractionally irradiated with doses from 34203600 cGy. The remaining seven patients (excluding the lost patient) did not undergo further treatment after GKS. There was no diffe rence in survival (p=0.382) (Figure 1 ) or control rate (71.4% vs. 88.9%, p=0.375) (Figure 2 ) between the patients treated with GKS and those with GKS followed by WBSRT and Chemo.
Three patients died. One died 2 months after GKS due to disease progression. The second died 9 months after radiosurgery with ventricular and spinal spread. The third died 18 months following multiple recurrences; however, the MRI of this patient taken 3 months after GKS revealed a sa tisfactory decrease in tumor size.
The mean KPS at 6 months after GKS (excluding those who died or were lost to followup) was 94.6, compared to 63.8 when they were first admitted to hospital. No obvious neurological deficits or complications, such as brain edema or cerebral radiation necrosis, were attributable to GKS.
selected cases

Case 1
A 27yearold man complained of a 1month history of headache and vomiting. Cranial MRI revealed a lesion with enhancement in the pineal region (Figure 3) . VPS was performed, followed by GKS with a marginal dose of 13 Gy and a 50% isodose line. Four months later, the patient underwent WBSRT with a dose of 3600 cGy, as well as Chemo. Followup confirmed a CR for more than 56 months.
Case 2
An 18yearold boy complained of headache that had las ted for 10 days. MRI showed an enhanced lesion in the pineal region (Figure 4) . The patient only underwent GKS, and the tumor reduced 3 months later. However, a small enhanced lesion was still present on MRI 6 months after GKS, but did not show any obvious changes at later followup assessments.
Case 3
A 45yearold man complained of headache for 15 days. MRI revealed an enhanced lesion in the pineal region (Fi gure 5A), and GKS was performed followed by WBSRT at a dose of 3420 cGy, as well as Chemo with temozolamide 3 months later. At 4 months after GKS there was a minor change in the lesion, with tumor seeding to the fourth ventricle ( Figure 5B ). The tumor showed PG at 7 months with ventricular and spinal spread ( Figure 5C ), and the patient died 9 months after GKS.
DIscussIoN
Compared to conventional irradiation, GKS is a better treatment tool for PRT patients. It can greatly protect adjacent brain tissue while directing a high dose to the tumor. Kobayashi and colleagues 19 reported on their use of stereotactic gamma radiosurgery for 30 pineal and related tumors, among which 3 cases without histological diagnosis were initially treated with GKS. A CR was obtained in 1 case and PRs in 2 during a mean followup period of 23.3 months. In the present research of 17 cases, 9 cases had a CR, and 3 cases obtained a PR over a mean followup period of 33.3 months. The total response rate was 75%, and the control rate was 81.3%. Thirteen patients (81.3%) were alive at the end of followup. These outcomes were analogous to a previous report in which pathological diagnoses were proven 19, 20 . Good quality of life was also seen in the present patients. Many studies have reported that good outcomes were obtained with fewer complications, although more invasive diag nostic treatments were applied 13, 1925 . We recorded the KPS of patients at admission and 6 months after GKS (excluding those who died or were lost to followup). The mean KPS at the 6month followup was 94.6, compared to the KPS of 63.8 when patients were first admitted to the hospital. We did not find any evidence of obvious neurological deficits or complications, such as brain edema or cerebral radiation necrosis. Most of our patients were able to return to school or their previous job 1-3 months after treatment.
One of the factors underlying outcome is the radiosensitive nature of some PRTs, such as germinomas, which have 5year survival rates of roughly 90% with radiotherapy alone These tumors account for a higher rate of PRTs in Asia, and usually occur in males 17 . The male:female ratio in our patients was 15:2, which suggests that radiosensitive PRTs may have accounted for the majority of cases. According to this cha racteristic and preoperative imaging evaluations, we selected midrange doses for GKS compared to previous studies 20, 23 . Another factor was the minimal invasiveness of GKS. Conventional radiation therapy for PRTs usually produces sequelae, such as cognitive deficits, endocrinopathies, secon dary malignancies, growth arrest, and marrow suppression The risk for these morbidities is particularly high in young children and in patients with a long life expectancy
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. GKS can greatly protect adjacent brain tissue when delivering large singlefraction radiation doses to a focal area. In the publi shed research on PRTs treated with GKS 13, 1925 , obvious neurological deficit and complications were not typically attribu table to GKS. A similar result was also observed in our study.
Tumor markers, such as AFP and β-HCG, are useful prognostic factors, and all patients should undergo routine tests 14 .
We found that CR was most likely to be obtained in patients with negative markers regardless of whether they were trea ted with GKS only or GKS followed by WBSRT and Chemo. Our findings indicate that patients with positive markers are more likely to have malignant tumors, and those with both negative AFP and βHCG results may have the best outcomes following radiosurgery.
It is important to note that some PRTs have a certain rate of ventricular and spinal spreading. For example, 2-37% of germinomas have distant metastases after appa rent local cures 1 . This problem cannot be solved by GKS alone, as it treats a limited irradiation region. Hence, GKS followed by WBSRT and Chemo is theoretically the better choice for PRT patients with no or unclear pathological diagnoses. Endo and colleagues 21 reported that combined radiotherapy using GKS is effective for pineal germinoma and reduces the cost of treatment by shortening hospita lization. Hasegawa and colleagues 13 pointed out that multimodality therapy, inclu ding stereotactic radiosurgery, fractionated radiotherapy, and Chemo, is required for more aggressive pineal parenchymal tumors. One of our patients whose enhanced lesion disappeared at 3 months after GKS died of multiple recurrences at 18 months, which might be attributable to GKS monothe rapy without adjunct WBSRT and chemotherapy. However, a difference in survi val and control rates between GKS only and GKS followed by WBSRT plus Chemo was not observed in this retrospective study. This may be because of the small sample size. For further studies, it remains an open question whether every patient with a negative pathological diagnosis should routinely receive WBSRT and Chemo after initial GKS.
In conclusion, GKS may be an alternative strategy in a subset of PRT patients who have negative pathological diagnoses, and good quality of life can be obtained with a low risk of complications. 
